NUCLEOLIN and amyotrophic lateral sclerosis: The distribution of the current and previously reported mutations in ATP13A2 in HSP, KRS, ALS, and NCL (Park, Blair, & Sue, 2015; Spataro et al., 2019) is depicted in Figure 1f.